Company profileNutraceutical & supplements#197 of 1,318 in Pakistan✓ No DRAP alerts

Regal Pharmaceuticals DML: 000839

Nutraceutical & supplement manufacturer · 92 registered products

92 registered products 34 distinct molecules 0 DRAP alerts
92 of this company's registrations sit in the DRAP category “Nutritional Supplement / Multivitamin”, which is registered as a category rather than by molecule — so a low molecule count reflects how supplements are registered, not a small portfolio. Nutraceutical manufacturers advertise direct to consumers and are among the largest marketing spenders in the Pakistani market.

Company overview

92
registered products
34
distinct molecules
0
therapeutic classes
0
DRAP alerts

Regal Pharmaceuticals DML: 000839 is a nutraceutical and dietary-supplement manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 92 product registrations. It is the 197th largest registrant in Pakistan by product count. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by Regal

53 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

53
ceilings with an approval date
0
not revised in 2+ years
2025
oldest approval year
202553

Top molecules by brand count

Nutritional Supplement / Multivitamin78 brands
Metronidazole ...... 500 Mg1 brand
Cefotaxime ......1Gm1 brand
Cefotaxime ....250Mg1 brand
Cefotaxime ...... 500 Mg1 brand
Cefotaxime1 brand
Clarithromycin ...... 125 Mg1 brand
Clarithromycin ...... 250 Mg1 brand

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official20 products · Rs 84.98 – Rs 874.61
Median across source: Rs 265.21

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

SEMOS PHARMACEUTICALS (PVT) LTD. holds 43 molecules not in this portfolio
AmodiaquineAmodiaquine 150MgArtemetherArtesunateAscorbic AcidBisacodyl
Hamaz Pharmaceuticals (Pvt) Ltd. holds 32 molecules not in this portfolio
AcyclovirAmoxicillinAscorbic AcidAtorvastatinAzathioprineAzithromycin Azithromycin Dihydarte
ZAFA PHARMACEUTICAL LABORATORIES (PVT) LTD. holds 139 molecules not in this portfolio
AlbuterolAminophyllineAmlodipineAmlodipine BaseAmmonium ChlorideAmmonium Chloride Containing Expectorants

Get the full profile for Regal

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.